Akero Therapeutics Announces Two Financing Transactions With Pfizer Inc. And Hercules Capital, Inc. Providing Access To Up To $125 Million
Round Type
Funding Round
South San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced two financing transactions. The first is a $25 million equity investment by Pfizer Inc. (NYSE: PFE) at $9.90 per share
Quick answer
Akero Therapeutics raised an undisclosed amount in a Funding Round round, dated June 16, 2022. Akero Therapeutics is based in South San Francisco, California, United States.
- How much did Akero Therapeutics raise?
- Akero Therapeutics raised an undisclosed amount in a Funding Round round on June 16, 2022.
- What does Akero Therapeutics do?
- Akero Therapeutics, Inc. is a clinical-stage company developing transformational treatments for patients with serious metabolic disease.
- Where is Akero Therapeutics based and how big is it?
- Akero Therapeutics is based in South San Francisco, California, United States.
- Who are the decision-makers at Akero Therapeutics?
- Fundz holds 3 contacts at Akero Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Akero Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Theriva Biologics raised $3M (Seed) on July 29, 2022.
- Elevation Oncology raised $50M (Debt Financing) on July 28, 2022.
- Vicinitas Therapeutics raised $65M (Series A) on July 28, 2022.
- Biofrontera raised $7.1M on July 27, 2022.
- Genetika+ raised an undisclosed amount (Funding Round) on July 26, 2022.
- Iveric Bio raised an undisclosed amount (Debt Financing) on July 26, 2022.
Who to call at Akero Therapeutics, and when
A new round usually means Akero Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Akero Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Akero Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Akero Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Akero Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Akero Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.